Cheng Sohanya Roshan

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Cheng Sohanya Roshan's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-14
S Sale
28,814 +48.3%
228.41
US$4,490,847 		28,814 +48.3% 228.41 US$4,490,847
2026-03-03 2026-03-02
S Sale
66,193 -11.2%
340.57
US$4,531,690 		66,193 -11.2% 340.57 US$4,531,690
2025-09-16 2025-09-15
S Sale
30,537 -49.7%
329.80
US$3,023,417 		30,537 -49.7% 329.80 US$3,023,417
2025-03-06 2025-03-04
S Sale
3,445 -9.1%
6.29
US$21,669 		3,445 -9.1% 6.29 US$21,669
2024-09-05 2024-09-04
PlS Planned sale
5,356 -1.3%
0.72
US$3,866 		5,356 -1.3% 0.72 US$3,866
2024-03-04 2024-03-01
S Sale
5,109 -1.3%
1.20
US$6,131 		5,109 -1.3% 1.20 US$6,131
2024-03-04 2024-02-29
S Sale
21,840 -5.2%
1.17
US$25,553 		21,840 -5.2% 1.17 US$25,553
2023-09-05 2023-09-01
S Sale
7,415 -3.5%
1.33
US$9,872 		7,415 -3.5% 1.33 US$9,872
2023-06-12 2023-06-08
PlS Planned sale
1,839 -0.9%
2.35
US$4,322 		1,839 -0.9% 2.35 US$4,322
2023-03-02 2023-03-01
S Sale
11,239 -5.1%
3.03
US$34,045 		11,239 -5.1% 3.03 US$34,045
2022-06-14 2022-06-13
S Sale
1,485 -1.6%
5.20
US$7,722 		1,485 -1.6% 5.20 US$7,722
2022-06-14 2022-06-13
S Sale
66 -0.1%
5.35
US$353 		66 -0.1% 5.35 US$353